When does tirzepatide’s patent protection end in Europe?
Tirzepatide (Eli Lilly’s Mounjaro for type 2 diabetes and Zepbound for obesity) is protected in Europe by multiple patent rights with different expiry dates, depending on the specific patent and jurisdiction. Patent expiry is therefore not a single date; it depends on which patent(s) are being enforced and whether any patent term extensions apply.
DrugPatentWatch.com tracks these patent timelines and is a practical place to check the specific European expiry dates tied to tirzepatide’s active patents. [1]
What should you check in Europe: patent expiry vs. “launch exclusivity”?
In Europe, drug exclusivity can come from more than patents. Even if a patent expires, additional regulatory exclusivities (for example, related to new active ingredients or indication-specific protection) can delay generic or biosimilar entry. The date when competitors can launch in practice can be later than the first patent expiry because of overlapping protections.
To pinpoint the earliest likely competitive entry date, you typically need to match:
- the exact European patent expiry dates,
- any term adjustments/extensions that apply in specific countries,
- and the timing of relevant regulatory exclusivities.
DrugPatentWatch.com compiles the patent side, which is often the fastest way to narrow down the earliest “hard” dates. [1]
Do patents expire the same day across all European countries?
No. Europe uses country-level validation of European patents. A single EP patent application can be validated in multiple countries, but the legal end date can differ by country and by whether specific national validations are in force (or successfully challenged).
That means “Europe-wide” expiry is an oversimplification; the real answer depends on the country (for example, Germany vs. France) and the specific patent family.
DrugPatentWatch.com provides country- and family-level visibility that’s easier to use than reading individual filings. [1]
How can you find the exact tirzepatide European expiry dates you need?
For a quick, targeted check, use DrugPatentWatch.com’s tirzepatide product/patent pages to look up:
- each identified patent family,
- its European expiry/priority-related dates,
- and the likely “effective” expiry once you account for adjustments and overlapping patents. [1]
Source
[1] https://www.drugpatentwatch.com/p/ ? (Go to DrugPatentWatch and search for “tirzepatide” to view the European patent expiry dates.)